Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004630 |
---|---|
Receipt number | R000005527 |
Scientific Title | Study of Bevacizumab + Irinotecan + S-1 therapy in metastatic colorectal cancer with KRAS mutant type |
Date of disclosure of the study information | 2010/11/30 |
Last modified on | 2012/12/10 03:09:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/11/30 01:57:11 | ||
2 | Update | 2012/12/10 02:51:23 | Public title Public title Acronym Acronym |
|
3 | Update | 2012/12/10 02:53:19 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2012/12/10 03:09:24 | Key inclusion criteria Key inclusion criteria Target sample size |